A detailed history of Macquarie Group LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Macquarie Group LTD holds 43,334 shares of TEVA stock, worth $799,512. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,334
Previous 44,075 1.68%
Holding current value
$799,512
Previous $621,000 13.37%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$12.78 - $17.4 $9,469 - $12,893
-741 Reduced 1.68%
43,334 $704,000
Q1 2024

May 14, 2024

BUY
$10.67 - $14.43 $106,081 - $143,463
9,942 Added 29.13%
44,075 $621,000
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $6,382 - $8,355
786 Added 2.36%
34,133 $356,000
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $34,378 - $49,177
-4,596 Reduced 12.11%
33,347 $340,000
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $37,418 - $49,215
-5,197 Reduced 12.05%
37,943 $285,000
Q4 2022

Feb 21, 2023

BUY
$7.95 - $9.48 $51,539 - $61,458
6,483 Added 17.69%
43,140 $393,000
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $1,440 - $2,509
-210 Reduced 0.57%
36,657 $296,000
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $60,833 - $85,727
-8,243 Reduced 18.27%
36,867 $278,000
Q4 2021

Feb 11, 2022

SELL
$7.9 - $10.19 $440,504 - $568,194
-55,760 Reduced 55.28%
45,110 $361,000
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $74,406 - $90,388
8,879 Added 9.65%
100,870 $982,000
Q2 2021

Aug 13, 2021

SELL
$9.9 - $11.56 $153,083 - $178,752
-15,463 Reduced 14.39%
91,991 $910,000
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $4.32 Million - $5.54 Million
-501,700 Reduced 82.36%
107,454 $1.04 Million
Q3 2020

Nov 13, 2020

BUY
$8.57 - $12.69 $426,151 - $631,022
49,726 Added 8.89%
609,154 $5.49 Million
Q2 2020

Aug 11, 2020

SELL
$8.12 - $13.12 $11.9 Million - $19.2 Million
-1,463,872 Reduced 72.35%
559,428 $6.9 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $107,092 - $175,808
16,400 Added 0.82%
2,023,300 $19.8 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $4.3 Million - $8.33 Million
530,000 Added 35.89%
2,006,900 $18.5 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $22.5 Million - $28.9 Million
1,445,400 Added 4588.57%
1,476,900 $23.2 Million
Q4 2018

Feb 15, 2019

SELL
$14.59 - $23.84 $10,213 - $16,688
-700 Reduced 2.17%
31,500 $485,000
Q3 2018

Nov 15, 2018

SELL
$21.06 - $25.65 $2.16 Million - $2.63 Million
-102,700 Reduced 76.13%
32,200 $693,000
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $385,710 - $568,330
-23,000 Reduced 14.57%
134,900 $3.28 Million
Q1 2018

May 11, 2018

SELL
$16.68 - $22.07 $80,064 - $105,936
-4,800 Reduced 2.95%
157,900 $2.7 Million
Q4 2017

Feb 15, 2018

SELL
$11.23 - $19.1 $47.7 Million - $81.1 Million
-4,245,631 Reduced 96.31%
162,700 $3.68 Million
Q3 2017

Nov 08, 2017

BUY
$15.41 - $32.17 $67.9 Million - $142 Million
4,408,331
4,408,331 $77.6 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.